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Abstract 41 
G protein-coupled receptors (GPCRs) are involved in numerous physiological 42 
processes and are the most frequent targets of approved drugs. The explosion in the 43 
number of new 3D molecular structures of GPCRs (3D-GPCRome) during the last 44 
decade has greatly advanced the mechanistic understanding and drug design 45 
opportunities for this protein family. Molecular dynamics (MD) simulations have become 46 
a widely established technique to explore the conformational landscape of proteins at 47 
an atomic level. However, the analysis and visualization of MD simulations require 48 
efficient storage resources and specialized software. Here we present GPCRmd 49 
(http://gpcrmd.org/), an online platform that incorporates web-based visualization 50 
capabilities as well as a comprehensive and user-friendly analysis toolbox that allows 51 
scientists from different disciplines to visualize, analyse and share GPCR MD data. 52 
GPCRmd originates from a community-driven effort to create the first open, interactive, 53 




G protein-coupled receptors (GPCRs) are abundant cell surface receptors accounting 58 
for ~4% (800) of all human genes. They play a vital role in signal transduction by 59 
regulating numerous aspects of human physiology and are the targets of 34% of the 60 
drugs approved by the US Food and Drug Administration1. Important advances in 61 
protein engineering, X-ray crystallography and cryo-electron microscopy (cryo-EM) 62 
during the past decade have led to an exponential increase in the number of available 63 
GPCR structures (3D-GPCRome) deposited in the Protein Data Bank (PDB) (GPCRdb 64 
http://gpcrdb.org/structure/statistics, 2019). This rapid growth has fueled the 65 
development of the GPCRdb2, an online resource for GPCR reference data, analysis, 66 
visualization and data-driven experiment design. This resource provides a wide range of 67 
tools including a knowledge-based resource for GPCR crystal and cryo-EM structure 68 
determination3.  69 
 70 
3 
However, static high-resolution structures provide little information on the intrinsic 71 
flexibility of GPCRs, a key aspect to fully understand their function. Important advances  72 
4 
 73 
Fig. 1: GPCRmd framework. GPCRmd is an online resource for storage, streaming, and 74 
analysis of GPCR MD simulation data from individual contributions and bi-annual collective 75 
5 
updates. An intuitive search algorithm allows for comprehensive screening of the database. (a) 76 
The user obtains detailed information about the simulation data via the simulation report. (b) A 77 
GPCR-specific workbench enables interactive visualization (GPCRmd viewer) and analysis 78 
(GPCRmd toolkit) for individual simulations. (c) Finally, the comparative analysis and clustering 79 
of multiple MD simulations helps finding relationships between receptors based on nine different 80 
molecular interaction types.  81 
 82 
 83 
in the computer science field have transformed computer simulations into a very 84 
powerful technique to explore protein conformational landscapes. In particular, all-atom 85 
molecular dynamics (MD) simulations have proven useful to complement experiments 86 
and characterize GPCR fluctuations at the atomic level4. Likely due to technical and 87 
sustainability limitations, only a modest number of online resources cover MD 88 
simulations (reviewed in 5). Recent large improvements of internet bandwidth, 89 
compression of simulation data, and storage capacities now enable faster and larger 90 
online repositories that host atom trajectories from MD simulations. Moreover, new 91 
visualization6 and online file-sharing7,8 tools have opened the door to streaming and 92 
remotely inspecting MD trajectories online, thereby removing the need for specialized 93 
MD software5.  94 
 95 
Here we present the GPCRmd platform (Fig. 1), the first open-access and community-96 
driven research resource for sharing GPCR MD simulations with the aim of mapping the 97 
entire 3D-GPCRome. This new resource paves the way for GPCR scientists from very 98 
different disciplines to perform comparative studies on universal aspects of GPCR 99 
dynamics. We showcase the potential of GPCRmd for exploring key aspects of GPCR 100 
dynamics by performing comparative analyses of internal water molecules and sodium 101 
ion binding in multiple GPCR MD simulations. The open and intuitive design of the 102 
GPCRmd platform will not only foster interdisciplinary research and data reproducibility, 103 
but also transparent and easy dissemination of GPCR MD simulations.  104 
 105 
Results 106 
MD simulations from all GPCR classes structurally solved to date  107 
6 
GPCRmd is a community-driven resource that provides direct and interactive 108 
visualization of MD trajectories, and that is only contingent on a web browser. As a 109 




Fig. 2: The 3D-GPCRome. Mapping the GPCR structures contained in the first GPCRmd 114 
release onto the 3D-GPCRome tree. The first GPCRmd dataset of simulated structures (191 115 
systems at the time of manuscript preparation) covers 100% of GPCR classes, 71% of 116 
receptors subtypes, and 80% of GPCR families with solved structure at the time of writing, and 117 
7 
accounts for approximately 35% of all GPCR structures deposited in the PDB (black PDB 118 
identifiers). Colored circles differentiate between active (green), intermediate (yellow), or 119 
inactive (red) receptor states.  120 
 121 
 122 
platform grants easy access for both computational and non-expert scientists. 123 
Moreover, we equipped it with a comprehensive set of tools to easily analyse molecular 124 
interactions and protein motions involving conserved, pharmacologically relevant, or 125 
disease-related residues and structural motifs potentially involved in GPCR function 126 
(Fig. 1b,c). In adherence to the Findable, Accessible, Interoperable, and Reusable 127 
principles for scientific data management9, GPCRmd provides open access to all of its 128 
data and simulations protocols (Fig. 1a). Corresponding data are deposited either by 129 
individual contributions or bi-annual updates from the GPCRmd community. 130 
 131 
We initiated the GPCRmd database by creating a comprehensive MD dataset including 132 
at least one representative structure from each of the four structurally characterized 133 
GPCR classes. To allow for comparison of ligand-induced effects across receptors, this 134 
first set comprises 95 PDB identifiers from 52 different receptor subtypes (Fig. 2) either 135 
in their apo form or bound to a natural ligand, surrogate agonist, or antagonist (see 136 
Methods). To generate reproducible data, we carefully designed a common protocol for 137 
the collective set-up and simulation of all structures listed in Figure 2 (see Methods) and 138 
made it publicly available at https://github.com/GPCRmd/MD-protocol. Each system 139 
was simulated for 500 ns in three replicates (total time 1.5 µs) allowing for structure 140 
relaxation as well as sampling of receptor flexibility. At the time of writing, the GPCRmd 141 
platform holds 570 GPCR MD simulations from the GPCRmd community plus 45 142 
simulations from individual contributions totalling to an aggregated simulation time of 143 
408 µs. 144 
 145 
GPCRmd viewer: sharing and interactive visualization of GPCRs in motion  146 
To provide easy sharing and interactive visualization of GPCR MD simulations within 147 
the 3D-GPCRome, we created the GPCRmd viewer (Fig. 3). This viewer builds on 148 
8 
MDsrv7, a recently published tool that allows easy trajectory sharing and makes use of 149 
the interactive capabilities of the popular web-based structure viewer NGL6.  150 
 151 
The GPCRmd viewer provides interactive structural analysis of the simulations through 152 
on-click actions (Fig. 3b). To account for the fact that almost 25% of the GPCR 153 
functional sites show an average of at least one polymorphism, we mapped all GPCR 154 
variants10 and site-directed mutations11 from the GPCRdb2 to each GPCR structure. 155 
Activation of the modes ‘Show variants’ or ‘Show mutations’ displays, respectively, each 156 
variant or mutation as small beads (Fig. 3b). A click on a bead reveals further 157 
information on the variant / mutation, including a link to experimental data and the 158 
original publication. A separate on-click mode, ‘Show distances’, exploits NGL6 to 159 




Fig. 3: The GPCRmd viewer. Interactive visualization of GPCR MD simulations allows for (a) 163 
streaming simulations, (b) structural mapping of mutation data and clinical variants, (c) 164 
predefined selections of simulation components and ligand binding sites, (d) customized 165 
selections that enable tailored visualization of trajectories, (e) knowledge-based selections for 166 
visualization of GPCR conserved regions, and (f) density maps allows for comparison between 167 
experiments and MD simulations. A set of predefined, custom and knowledge-based selections 168 
enables quick exploration of particular regions of the map such as the ligand binding pocket. 169 
Flexible options allow users to change the color of the map type (classical fo-fc or composite 170 
2fo-fc), style (e.g. wireframe / contour), or the surface and zoom levels.  171 
 172 
The powerful selection capabilities of the viewer (Fig. 3c-e) enable fast inspection of 173 
trajectories. Standard selections quickly visualize any molecule type in the simulation, 174 
neighboring molecules at a custom distance of each other, or specific positions along 175 
the protein sequence. It is worth noting that the GPCR viewer makes use of GPCRdb 176 
generic residue numbering12 by automatically linking each residue to its respective 177 
index position. Importantly, predefined knowledge-based selections enable more 178 
specific displays such as residues within 2.5   of the ligand (Fig. 3c), individual GPCR 179 
helices, or highly conserved positions and functional motifs (Fig. 3e). In addition,  the 180 
NGL selection language (see Documentation) enables the use of custom selection 181 
keywords to create tailored representations of any atom or part of the trajectory loaded 182 
in the GPCRmd viewer (Fig. 3d). Since several of these keywords stand for the 183 
chemical nature or secondary structure of proteins, they are particularly helpful for 184 
visual analysis of GPCR dynamics.  185 
 186 
Furthermore, the GPCRmd viewer provides visualization of X-ray and electron 187 
microscopy (EM) density maps from the PDB. This allows for atomic-level comparison 188 
of the GPCR conformational landscape inferred in structurally determined structures 189 
and observed in MD simulations (Fig. 3f). 190 
 191 
GPCRmd toolkit: investigation of GPCR dynamics through interactive analysis  192 
The GPCRmd toolkit provides intuitive analysis of the MD simulations by 193 
complementing and directly interacting with the GPCRmd viewer (Fig. 1b, left). The 194 
toolkit allows to compute custom distances, Root Mean Square Deviation (RMSD), and 195 
averaged water density maps for individual simulations (Fig. 1b, right). In addition, it 196 
10 
provides interactive tools to qualitatively and quantitatively compare the non-covalent 197 
landscape of contacts for the entire GPCRmd dataset (Fig. 1b, right).  198 
 199 
Interaction network tool. To easily identify relevant non-covalent contacts in GPCRmd 200 
simulations, the GPCRmd toolkit uses Flareplots13, an interactive circular representation 201 
of contact networks that can be displayed per frame or summarized for the complete 202 
trajectory (Fig. 4, right). The interaction network tool automatically integrates the 203 
GPCRmd viewer with the GPCRmd toolkit, making it straightforward to detect, for 204 
instance, differences in the hydrogen bonding network dynamics between active and 205 
inactive receptor simulations. The current version of the interaction network tool focuses 206 
on intra- and inter-helical interactions including nine different types of non-covalent 207 
interactions (see Methods). 208 
 209 
Interaction frequency tools. The GPCRmd toolkit provides two dedicated tools to study 210 
key electrostatic interactions, namely hydrogen bonds and salt bridges. The hydrogen 211 
bonds tool identifies GPCR intra- and intermolecular hydrogen bonds formed during the 212 
simulation, whereas the salt bridges tool identifies GPCR intramolecular salt bridges. 213 
Moreover, these tools allow studying the interplay between the receptor and the 214 
membrane by computing protein-lipid interactions. Furthermore, it can identify protein 215 
residues involved in ligand binding through the ligand-receptor contacts tool. The tool 216 
outputs the interaction strength at each residue by computing its contact frequency (Fig. 217 
1b, right). All three contact tools provide interactive visualization of the results in the 218 
GPCRmd viewer.  219 
 220 
RMSD tool. The GPCRmd toolkit can monitor a change in distance between any pair of 221 
atoms during the simulation. Alternatively, per-frame atom distances can be measured 222 
and displayed in the viewer via on-click actions. While distance measurements can 223 
provide relevant information on protein structure (e.g. functionally-relevant protein 224 
motions, bond formation / breaking, etc.), RMSD calculations are more suited to 225 
quantify structural stability and conformational changes. The RMSD tool measures the 226 
structural difference of protein and ligand atoms at any point in the simulation with 227 
11 
respect to the initial frame. Therefore, it can be used to monitor simulation integrity or 228 
structural deviations throughout the simulation. Both tools generate time course plots 229 
(Fig. 1b, right) that can interactively link each data point to its respective frame in the 230 
viewer.  231 
 232 
 233 
Fig. 4: Interaction network tool. Interactive visualization and analysis of intramolecular 234 
contacts. Summary plot for the hydrogen bonding network (i.e. average over the entire 235 
trajectory) obtained by selecting hydrogen bonds as interaction type. Circular plots (right) for the 236 
inactive β2AR in complex with timolol (PDB ID 3D4S, upper panel) and the active β2AR in 237 
complex with adrenaline (PDB ID 4LDO, lower panel), where line thickness represents contact 238 
frequency. For clarity, only contact frequencies over 10% are shown. Comparison of these plots 239 
reveals important differences specifically at the intracellular coupling site. The inactive receptor 240 
12 
displays contacts that help maintain the receptor in a closed state, such as the characteristic 241 
ionic lock between R3x50 and E6x3014, a TM5-TM6 linkage established by Y5x58 to the 242 
backbone of L6x43, and a TM6-Helix8 connection between K6x29 and D8x49. Such contacts 243 
are missing in the active β2AR conformation. The user can interactively explore the dynamics of 244 
the plotted contacts in the circular plot (right panel) in a structural context (left panel). Residues 245 
are numbered according to their GPCRdb generic numbering scheme12. 246 
 247 
Water volume distribution tool. Due to the vital role of internal water molecules in 248 
GPCRs15, we equipped the GPCRmd toolkit with a water density map tool. This tool can 249 
quickly display an averaged water density map of the MD trajectory under study in the 250 
GPCRmd viewer (Fig. 1b, right), thus allowing to monitor, for example, the formation of 251 
the continuous internal water channel known to be essential for GPCR activation16. 252 
 253 
Tunnels and channels tool. Just like all proteins, GPCRs hold an intricate system of 254 
tunnels and channels that can facilitate the access of water, ions, lipids and ligands by 255 
connecting the outside environment to the receptor core17,18. Since these pathways may 256 
significantly change over time, we provided the GPCRmd toolkit with a tool to analyse 257 
and display tunnels and channels. The new widget allows users to select among the list 258 
of computed tunnels and channels to immediately display them in the GPCRmd viewer 259 
using different visualization schemes. 260 
 261 
Functional hotspots discovered through meta-analysis of GPCR simulations   262 
The GPCRmd platform can uniquely compare GPCR simulations within the 3D-263 
GPCRome (Figs. 1c and 2). We developed a module specifically comparing multifold 264 
GPCR simulations to uncover universal or distinct mechanisms governing the structural 265 
dynamics of these receptors. This module computes the contact frequency of each 266 
residue pair for multiple simulations and displays a global comparative analysis via an 267 
interactive heatmap plot (Fig. 5a, left). The tool also performs clustering analysis of the 268 
contact frequency data to hierarchically classify each receptor and display the resulting 269 
tree alongside the heatmap plot (Fig. 5a, left). To further facilitate the interpretation of 270 
large heatmaps, we added interactive analysis and visualization capabilities of selected 271 
clusters using Flareplots13 and NGL6. 272 
 273 
13 
To demonstrate the utility of the meta-analysis tool, and due to their critical role in 274 
receptor function15,16, we investigated the interaction fingerprint of water molecules in 275 
GPCRs. Along with previously described19 conserved water networks, this analysis 276 
revealed other water-mediated interactions that are conserved among different receptor 277 
subtypes and firstly reported here. For example, in line with Venkatakrishnan et al.19, 278 




Fig. 5: A water bridge signature revealed by comparative analysis using the GPCRmd. (a) 281 
Heatmap of water-mediated interactions of clusters belonging to the β2AR and OX2R. The plot 282 
displays each residue pair (columns) for each GPCR (rows). Green to red color scale stands for 283 
low to high contact frequency. Users can select up to nine different non-covalent interaction 284 
types to perform the analysis across the complete GPCRmd database or just using a custom 285 
subset of simulations. On-click actions provide detailed information on the specific interaction 286 
and system involved for each cell of the heatmap. (b) Representative water-mediated 287 
interactions for the investigated clusters are shown in circular plots. Corresponding structural 288 
depictions of interactions are found below the circular plots. This includes a water-mediated 289 
network connecting the allosteric sodium binding site 2x50 in TM2 with position 1x50 in TM1 in 290 
the β2AR and OX2R (highlighted in purple). This water network is extended from TM2 (2x50) to 291 
TM7 (7x49) in the OX2R cluster. Such a water network extension is not observed in the β2AR 292 
cluster due to closer proximity of residues 2x50 and 7x49, which enables direct, unmediated, 293 
contacts. Another conserved water-mediated feature is a bifurcated polar network linking TM6 294 
(6x47, 6x51) and TM7 (7x37) via helix backbones in the β2AR and the OX2R clusters 295 
(highlighted in green). Important differences between both clusters are two water-mediated 296 
connections, namely ICL1 (12x49) - H8 (8x49) (highlighted in orange) and TM3 (3x41) - TM4 297 
(4x56) (highlighted in grey), the latter one occurring in a region of the receptor facing the 298 
membrane and exclusively found in the β2AR cluster. Residues are numbered according to their 299 
GPCRdb generic numbering scheme12.  300 
 301 
adrenoceptor (β2AR) and OX2-receptor (OX2R) display a common water network that 302 
links TM1 (N1x50) and TM2 (D2x50) and a bifurcated network connecting TM6 (6x47, 303 
6x51) and TM7 (7x37) (Fig. 5). Our study shows that this bifurcated network is less 304 
prominent in active structures (Supplementary Figure 1). Taking into account that TM6 305 
undergoes large conformational changes upon receptor activation, it is tempting to 306 
speculate that uncoupling the interactions between individual water molecules in this 307 
bifurcated network represents a step during receptor activation.  308 
 309 
Likewise, our analysis reveals a water bridge between intracellular loop 1 (ICL1) and 310 
helix 8 (H8) only present in the β2AR (Fig. 5b, right). Further studies (e.g. site-directed 311 
mutagenesis) could be used in the future to investigate whether this water bridge 312 
contributes to the distinct coupling efficacy and/or specificity shown by the β2AR 313 
(principal signaling pathway: Gs family20) and OX2R (principal signaling pathway: Gs 314 
family, Gi/Go family, Gq/G11 family20). Finally, our collective analysis reveals a water 315 
bridge between TM3 (3x41) and TM4 (4x56) only found in the β2AR (Fig. 5b, right) and 316 
16 
likely related to the striking change in receptor stability observed upon mutation of 317 
residue E3x41 in experiments21. 318 
 319 
Exploiting the entire GPCRmd dataset: custom analysis of sodium ion 320 
interactions across class A GPCRs. 321 
We made the entire GPCRmd dataset available for download (see Methods), thus 322 
opening the door for the scientific community to perform comparative analyses of 323 
multiple simulations across several receptor structures, families, subtypes and classes. 324 
To demonstrate the value of such a comprehensive dataset, we studied sodium ion 325 
(Na+) interaction in GPCRs22, an almost universal, albeit poorly understood, mechanism 326 
of allosteric modulation of these receptors23. We analysed Na+ interaction to conserved 327 
orthosteric (3x32) and allosteric (2x50) residues in 183 simulations (61 different apo 328 
structures x 3 replicas) covering 26 different class A receptor subtypes. The markedly 329 
different frequencies of Na+ interaction with these two residues enable receptors to be 330 
clustered in three groups (I, II, and III, Fig. 6a,c). Note that our dataset (3 x 0.5 μs) 331 
provides valuable insights into sodium interaction sites but it is not sufficient to conclude 332 
about binding kinetics.  333 
 334 
In line with previous studies using multiple simulations24, our analysis shows that Na+ 335 
binds to D2x50 and/or position 3x32 in most of the receptor subtypes (Fig. 6a). Group I 336 
(serotonin, dopamine and nociception receptors) shows high sodium interaction 337 
frequencies to positions 3x32 and 2x50, the latter being stabilized by a hydrogen 338 
bonding network often composed of D2x50, S3x39, N7x45 and S7x46 (so-called as 339 
DSNS motif) (Fig. 6b). The high interaction frequency to both positions implicates that at 340 
times Na+ ions bind simultaneously to position 3x32 and the allosteric site at D2x50. 341 
This seems to be a consequence of a higher negative net charge at the extracellular 342 
side (Fig. 3c,d), which increases the local concentration of positively charged Na+ 343 
around the receptor entrance, and likely facilitates the simultaneous entrance of a 344 
second ion. Notably, despite a completely conserved DSNS motif, group II (β-345 
adrenergic and muscarinic receptors) shows surprisingly marginal interaction frequency 346 
17 
at D2x50, while still exhibiting a high interaction frequency at 3x32. Visual inspection of 347 
the simulation reveals  348 
 349 
 350 
Fig. 6: Allosteric Na+ ion interaction in class A GPCRs. (a) Na+ interaction frequency at 351 
D3x32 (green) and D2x50 (orange) in class A GPCRs across 61 structures including 26 352 
different receptor subtypes. Receptor subtypes and 3D structures are identified by UniprotKB 353 
and PDB identifiers, respectively. The radar plot shows the prevalence of sodium interactions (0 354 
to 100%) over the total accumulated simulation time of 1.5 µs (3 x 0.5 µs). (b) Sequence 355 
alignment of sodium binding sites for the GPCR subtypes included in the simulated dataset. 356 
Allosteric binding consists of a multi-step binding process typically initiated with accumulation at 357 
the extracellular receptor side followed by receptor penetration through the orthosteric binding 358 
site (visiting D3x32, if present) before progressing to the allosteric site D2x50. (c) GPCRs can 359 
be classified into three groups based on the sodium interaction profile. The interaction profile is 360 
driven by the structural features of the sodium entrance channel. (d) Extracellular net charge 361 
and receptor entrance of a second ion.  362 
18 
hydrophobic barriers that hamper Na+ passage from 3x32 to 2x50 (Fig. 6c), in line with 363 
previous MD simulation studies24,25. In contrast to group II, we find high interaction 364 
frequencies at position 2x50 for group III and none or only marginal contacts with 3x32. 365 
Most receptors of this group (e.g. adenosine A1A and A2A, or the chemokine receptor 366 
CXCR4) lack an aspartate in position 3x32 allowing for direct diffusion to position 2x50 367 
(Fig. 6c). Interestingly, despite having a D3x32 (Fig. 6b), only low binding is observed 368 
during the simulated time frame at this position for a small subgroup of receptors 369 
including histamine H1 and opioid μ and δ receptors. More simulation time would be 370 
required to improve the sampling of ion binding to D3x32. Finally, in a particular subset 371 
of receptors, Na+ binds neither to D2x50 nor to position 3x32 within the studied time 372 
frame (group IV, Fig. 6a). In fact, slower Na+ binding kinetics has previously been 373 
reported24 and could be the consequence of blocked access to the binding site from the 374 
extracellular side (e.g. receptors taking up ligands from the lipid bilayer).  375 
 376 
While our results confirm the essential role of D2x50 for allosteric sodium binding15,26 in 377 
class A GPCRs, they also reveal that the presence or absence of D3x32 in the 378 
orthosteric binding site determine distinct Na+ binding profiles. This analysis exemplifies 379 
the potential of the comprehensive GPCRmd dataset to investigate how GPCR 380 
sequence, structure and dynamics can jointly contribute to receptor allosteric 381 
modulation.  382 
 383 
Discussion 384 
In the last decade, static structures in the 3D-GPCRome have predominantly been 385 
described as either active, intermediate, or inactive states. However, a growing body of 386 
research suggests that GPCRs are not two- or three-state systems but exhibit a wide 387 
range of conformational states with sometimes subtle yet important differences. While 388 
several experimental techniques such as nuclear magnetic resonance (NMR)27, double 389 
electron-electron resonance (DEER)28, or single-molecule fluorescence energy transfer 390 
(smFRET)29 have provided relevant insights into the dynamics and flexibility of GPCRs, 391 
MD simulations have emerged as the most promising opportunity to study the 392 
complexity of GPCR conformational dynamics in atomistic detail4. Moreover, MD 393 
19 
simulations can resolve mechanistic elements at time scales and conditions that are not 394 
always accessible with experimental techniques.  395 
 396 
We have demonstrated the utility of the GPCRmd platform by performing comparative 397 
analyses across multiple receptors of two relevant aspects of GPCR biology, namely 398 
water network and allosteric Na+ interaction analysis. Using GPCRmd tools, we 399 
pinpointed differences in the water-mediated networks of the OX2R and the β2AR 400 
potentially involved in receptor activation and G protein coupling. In addition, we 401 
showcase the power of exploiting the GPCRmd dataset offline by downloading a 402 
comprehensive group of class A GPCR simulations and using external means to 403 
investigate Na+ interactions. This study allowed to classify receptors in different groups 404 
based on the interaction profile of Na+ to the orthosteric and/or allosteric sites. 405 
Interestingly, our study suggests that the probability of ion entrance into the orthosteric 406 
site is modulated by the extracellular net charge of the receptor.   407 
 408 
A platform for interdisciplinary investigation of the 3D-GPCRome 409 
The GPCRmd is designed to facilitate interactions and data exchange between GPCR 410 
scientists of different disciplines including structural and evolutionary biologists, 411 
computational and medicinal chemists, protein engineers, and structural biologists 412 
(Table 1). Our tool will become a useful asset for experimental laboratories by providing 413 
open access to the dynamic context of specific GPCRs, hence directing or assisting 414 
functionally relevant experiments such as cross-linking or mutagenesis studies. 415 
Similarly, protein engineers and structural biologists will now be able to employ the 416 
GPCRmd workbench to quickly identify specific flexible regions that potentially require 417 
protein stabilization. 418 
 419 
Moreover, the GPCRmd will be of great benefit to medicinal chemists and drug 420 
designers. For the first time, they will be able to quickly use atomic-level information on 421 
the stability / strength of specific ligand-receptor interactions, and the binding of water 422 
molecules or ions using the ligand-receptor contacts or water volume distribution tools 423 
(see Fig. 1 and Table 1). In addition, drug design scientists can use GPCRmd to 424 
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investigate potential ligand binding and unbinding pathways based on the dynamics of 425 
specific structural elements such as loops, hence aiding the design of new or improved 426 
compounds. Furthermore, the GPCRmd can provide valuable structural insights into the 427 
location of natural variants and its potential impact on drug binding or receptor 428 
functionality. Our cross-referenced data allows easy mapping of variants and site-429 
directed mutations onto the receptor structure and investigation of their dynamics during 430 
the simulations (Fig. 1b, right, and Fig. 4b). This could guide further investigations to 431 
predict drug efficacy or adverse reactions in individuals with a specific variant and in 432 
turn support the selection of more efficacious and safer drug treatments. 433 
 434 
Beyond wet-lab applications, GPCRmd is an important dissemination resource for 435 
computational biologists, ranging from students and MD novices to MD experts and 436 
bioinformaticians from related fields. Our platform offers a harmonized database to 437 
perform future comparative studies across different MD setups, force fields, ligands, 438 
lipid compositions or GPCR variants, which offers a significant advantage over currently 439 
available archives or data repositories such as FigShare (https://figshare.com/) or 440 
Zenodo (http://zenodo.org). 441 
 442 
The GPCRmd consortium: reproducible and sustainable research in GPCR MD 443 
simulations 444 
This community-driven effort has laid the foundation of the GPCRmd consortium, an 445 
open community of GPCR computational researchers driving the centralization, 446 
dissemination, and development of open-source and reproducible analysis of massive 447 
amounts of GPCR MD data. We believe that GPCRmd will enhance the dissemination 448 
of scientific results by offering a platform to make published protocols and simulation 449 
data publicly available. This will promote transparency, consistency, and reproducibility 450 
in the field of GPCR dynamics. On the other hand, community engagement will 451 
overcome one of the most important challenges faced by this kind of resource, namely 452 
sustainability (Supplementary Note 1). The implementation of the GPCRmd consortium 453 
under the umbrella of the active European Research Network on Signal Transduction 454 
(ERNEST, https://ernest-gpcr.eu)30 will provide support to (a) foster the development of 455 
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new analysis tools (e.g. conformational analyses and dynamic pharmacophore models), 456 
and (b) increase the  457 
Table 1. Examples of how researchers from different scientific disciplines can make use of the 458 
GPCRmd database. 459 
User Usage GPCRmd features Added value 
Protein engineers 
Stabilizing proteins for crystallization. 
Detection of flexible receptor regions that require 
stabilization to improve crystallization success.   
GPCRmd workbench 
including the GPCRmd 
viewer and Toolkit 
Flexible receptor regions 




Retrospective refinement of experimental 
density maps 
(i) Detection of highly flexible regions that explain 
low-resolution regions in experimental density 
maps. 
  
(ii) Detection of stable water or ion binding sites 
that can explain unmatched electron density 
areas. 
  
(iii) Rotamers and protonation states. 
GPCRmd viewer. MD 




The water map tool in 
the GPCRmd toolkit 
Water and ion binding are 




Rotation states and 
corresponding protonation 
states are difficult to 
obtain from experimental 
density maps 
Biophysicists 
Study of interaction networks critical for 
receptor functionality. Search for receptor 
regions to implement linkers or signaling probes 
(FRET, NMR, etc.) to study receptor functionality. 
GPCRmd workbench 
including the GPCRmd 
viewer and Toolkit 
Receptor dynamics is not 




Structural relationships and diversity across 
different GPCRs. How does evolution (i.e. small 
sequence differences) impact receptor dynamics. 
Comparative receptor 
analysis and clustering 
tool 
Receptor dynamics is not 
available in experimental 
density maps 
Medicinal chemists & 
drug designers 
Improvement of drug-receptor interactions and 
design of new drugs. 
(i) Exploration of ligand-receptor contacts. 
  
(ii) Detection of indirect interactions (i.e. water or 
ion-mediated) that are crucial for ligand binding.  
  
(iii) Flexible and transient switches  
Ligand-receptor 
contacts and water 
volume distribution 
tools 
Stability of ligand-receptor 









Design of treatment strategies for 
personalized medicine. Estimation of the impact 
of polymorphisms / variants on drug response 
through their ability to alter drug-receptor 
interactions or receptor dynamics in regions 
relevant for receptor functionality (e.g. PIF motif, 
G protein coupling site).  
Cross-linked mutation 
and variant information 
The impact of 
polymorphism/variants on 
the strength of ligand-
receptor contacts or 
receptor dynamics cannot 




novices and experts, 
bioinformaticians) 
(i) Aid in experimental design and comparison of 
setup and results in terms of force field 
performance, impact of ligands, or mutations. 
  
(ii) Support for modelling dynamic regions able to 
adopt distinct conformations. 
  
(iii) Guide docking experiments based on the 
sampled conformational space.  
GPCRmd viewer for 
simulation streaming 
  




including the GPCRmd 
viewer and Toolkit 
Receptor dynamics are 
not available in 
experimental density 
maps 
Students & teachers 
Visually learning about protein dynamics: e.g. 
receptor inactivation, water channel formation in 
active receptor structures, allosteric binding of 
GPCRmd workbench 
including the GPCRmd 
viewer and Toolkit 
Dynamics cannot be 
visualized in printed form 
and trajectories are not 
22 




Data made available for scrutiny of molecular 
dynamics articles GPCRmd platform 
Transparency and 
reproducibility 
coverage of the 3D-GPCRome with future releases of the GPCRmd platform. While the 460 
first GPCRmd dataset from the consortium already maps more than 70% of GPCR 461 
subtypes within the 3D-GPCRome, future biannual releases as well as individual 462 
contributions from the scientific community will further increase this coverage bridging 463 
the gap between solved and simulated structures. 464 
 465 
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 532 
Methods 533 
MD simulations. The first GPCRmd includes 95 different GPCR structures either bound to their 534 
natural ligand (e.g. sphingosine-bound S1P1R), an agonist (e.g. ergotamine-bound 5HT2BR), or 535 
an antagonist (e.g. alprenolol-bound β2AR). In addition to ligand-bound structures, we included 536 
an apo form of each receptor by removing the ligand from its binding pocket. We carefully 537 
designed a common protocol for the collective set-up and simulation (Supplementary Note 2) 538 
phases of all structures. During the set-up phase, different expert members of the GPCR-MD 539 
community individually prepared each family of GPCR structures by refining / remodeling 540 
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Protein Data Bank (PDB) structures (e.g. missing residues, disulfide bridges, co-crystallization 541 
molecules, loop remodeling, etc.), placing missing water molecules30 and sodium ions, or 542 
assigning relevant protonation states (Supplementary Note 2). Next, each protein was prepared 543 
for simulation by embedding it in a lipid bilayer and adding water and ions to the system. Each 544 
system was equilibrated following a standard procedure previously outlined and discussed 545 
within the GPCR-MD community (Supplementary Note 2). Finally, the distributed computing 546 
platform GPUGRID31 was used to simulate 3 replicas of each system for 500 ns (i.e. 547 
accumulated 1.5 μs). We made all set-up and simulation protocols openly available at  548 
https://github.com/GPCRmd/MD-protocol.   549 
 550 
Database structure. The GPCRmd database and web interface were developed using Django 551 
Web Framework (v1.9), Python (v3.4), JavaScript libraries, jQuery 1.9, jQuery UI 1.11.2, and 552 
PostgreSQL 9. The structure of the database (Supplementary Figs. 2-8) is based on five main 553 
objects: protein objects identified by their sequence and their relationship with UniprotKB entries 554 
(Supplementary Fig. 2), molecular entities (molecule object) identified by an InChI32 generated 555 
with forced hydrogen connectivity (Supplementary Fig. 3), crystalized assembly (model) 556 
(Supplementary Fig. 4), molecular dynamics simulations (dynamics) objects (Supplementary 557 
Fig. 5), and chemical species (compound) identified by standard InChI. Supplementary Fig. 6 558 
shows the Entity Relationship (ER) diagram. Furthermore, we incorporated experimental data 559 
from IUPHAR33 and BindingDB34, and linked each main object to bibliographic references. 560 
GPCRdb2 tables were used to add standard nomenclatures to GPCR sequence residue 561 
numbers. 562 
 563 
Custom analysis. The whole GPCRmd repository is released as open source under the 564 
Creative Commons Attribution 4.0 International License hence enabling downloading and 565 
custom analysis of the comprehensive dataset. Each trajectory can be downloaded from its 566 
respective link at the simulation report page (see Documentation). We exemplified this usage by 567 
studying sodium ion binding across a selection of class A GPCRs within the GPCRmd dataset. 568 
The frequency of sodium ion binding to the closest oxygen atom of the carboxylic group (2 x Oϵ) 569 
of residues 3x32 and 2x50 were computed using a cutoff distance of 5 Å. Both highly conserved 570 
positions are normally aspartate residues. For non-conserved residues we used the following 571 
atoms: Gln (Nϵ, Oϵ), His (Nδ), Arg (Nϵ), Ala (Cγ), Val (2 x Cγ Hydrogen), Ile (2 x Cγ Hydrogen), 572 
Met (Sδ),  Phe (2 x Cδ), Tyr (2 x Cδ).  573 
 574 
GPCRmd viewer. The GPCR viewer uses builds on NGL 2.006 and MDsrv 0.3.57 and uses data 575 
from the PDB (rcsb.org35), the GPCRdb2, and the Genome Aggregation Database (gnomAD)36. 576 
On-click modes. Data for on-click variants and site-directed mutagenesis annotations are taken 577 
from the GPCRdb2,10,11 and include: generic GPCR numbers12, original and mutated residues, 578 
effect of the mutation in ligand binding (fold change), experiment type, ligand used for the 579 
experiment, and bibliographic reference. Variant data is obtained from the gnomAD36, and 580 
includes amino acid substitutions (canonical and variant), allele frequencies, and link to the 581 
gnomAD entry describing the variant. On-click selection capabilities build on NGL 2.0.06 web 582 
viewer, which allow the creation of different representation objects using the NGL selection 583 
language. GPCRmd selection capabilities also feature the GPCR generic numbering scheme12. 584 
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In this case, GPCRdb numbers are adapted to the NGL selection language through regular 585 
expressions. Experimental density maps are loaded from PDB and aligned to the first frame of 586 
the simulation displayed using NGL 2.0.06. The transformation matrix applied to the density map 587 
in order to perform the alignment is pre-computed using the Python library MDAnalysis 588 
v0.20.137.  589 
 590 
GPCRmd toolkit.  591 
Interaction networks. Non-covalent residue-residue interactions formed in the simulation are 592 
displayed using Flareplots13. To pre-compute interactions during the simulation, we used 593 
GetContacts13 in all interaction types except for hydrogen bonds, where we used the definition of 594 
Wernet and Nilsson. We manually integrated Flareplots and NGL to allow for interactivity 595 
between the GPCRmd toolkit and the GPCRmd viewer. 596 
Interaction frequencies. Hydrogen bonds are calculated using the “wernet_nilsson” module of 597 
MDtraj38. A hydrogen bond is defined using distance and angle cut offs between hydrogen 598 
donor (NH or OH) and acceptor (N or O) atoms as follows: 599 
 600 
	 < 	3.3	Å	 − 	0.00044	Å	 · 	 2 
 601 
where rDA is the distance (Å) between donor and acceptor heavy atoms, and δHDA is the angle 602 
(degrees) formed between the hydrogen atoms of donor and acceptor atoms. By default, the 603 
analysis does not consider hydrogen bonds between neighbouring residues and includes side 604 
chains as well as backbone atoms. Ligand-receptor contacts are computed using the 605 
compute_contacts module of MDtraj38. Salt bridge frequency is computed using the 606 
“compute_distances” module of MDtraj38. Salt bridges are defined as any combination between 607 
the sets {Arg-NH1, Arg-NH2, Lys-NZ, His-NE2, His-ND1} and {Glu-OE1, Glu-OE2, Asp-OD1, 608 
Asp-OD2} with atoms closer than 4 Å. Histidine atoms are only considered if the residue is 609 
protonated. The distance between atom pairs through the entire or strided trajectories is 610 
computed using the “compute_distances" module of MDtraj38. Atom pairs can be defined either 611 
using the “Show distances” on-click mode and imported to the tool, or NGL selection language 612 
instances.  613 
Root Mean Square Deviation (RMSD). RMSD is computed using the rmsd module of MDtraj38. 614 
The first frame of the trajectory is used as a reference structure by default. The atoms used for 615 
RMSD computation can be defined using the provided pre-selection in the GPCRmd toolkit (e.g. 616 
protein alpha carbons, non-hydrogen protein atoms, ligand, etc.).  RMSD is computed after 617 









where Natoms is the number of atoms for structure comparison, ri (1) is the position of atom i in 621 
the reference frame (i.e. trajectory frame 1) and ri (t) is the position of atom i at time t of the 622 
trajectory.  623 
26 
Water volume distribution. Water occupancy maps are pre-computed and stored on the server 624 
side using the VolMap tool of VMD39. Maps are generated only for oxygen atoms of a water 625 
molecule using a cutoff distance of 10 Å to the protein and a resolution of 1 Å. Atoms are 626 
treated as spheres using their atomic radii. The resulting isosurface is displayed in the GPCRmd 627 
viewer.  628 
Tunnels and channels. Tunnels and channels are pre-computed using the CAVER 3.0 629 
software40 and stored on the server side. We used as starting point coordinates for apo forms 630 
and receptor-ligand structures the center of mass of ligand-interacting residues in the respective 631 
PDB structure. Computations were carried out using a shell radius 3 Å, shell depth 4 Å, and a 632 
probe radius of 1.4 Å. Selected results are displayed in the GPCRmd viewer. 633 
 634 
Meta-analysis tool. Contacts are computed using GetContacts13 and results plotted as 635 
interactive heatmaps using the Bokeh visualization library (https://docs.bokeh.org/en/latest/). 636 
Contact frequencies per system are averaged over simulation replicas. For accurate 637 
comparison, residue contact pairs are aligned using the GPCRdb generic numbering scheme12. 638 
Hierarchical clustering uses the “linkage” function of the SciPy 0.18.141 library with default 639 
parameters. Dendrogram plots use the Plotly library (https://plot.ly/python/). 640 
 641 
Reporting Summary. Further information on research design is available in the Nature 642 
Research Reporting Summary linked to this article. 643 
 644 
Data availability  645 
The molecular dynamics data have been deposited in the GPCRmd database 646 
(http://gpcrmd.org/).  647 
 648 
Code availability  649 
Set-up, simulation, and analysis protocols are openly available at 650 
https://github.com/GPCRmd/GPCRmd.  651 
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Carazolol POPC Chloride Sodium ion
Water Binding site All




GPCRmd viewer GPCRmd toolkit


































Clustering based on 9 contact types GPCR clusters and heatmaps for contact frequencies
<- contact residue pairs ->

























Mutation  Fold     Exp. Type        Ligand     Ref














































































































































































































































































































































































































































































































































Structure selection                             ▼
β2 adrenergic receptor (2R4R)
Clear all
GPCRmd viewer
Trajectory ID: 10180 ▼




Experimental density map                     ▼
On click mode









Mutation  Fold           Exp. Type                     Ligand      Ref
S  ⇛ 3.717 Binding – Radioligand       TA-2005
competition/displacement
Asn 7x38 (312:P)
Variant       Type            Freq       Ref

































































































































































Polar/Electrostatic Non-polar Stacking<- contact residue pairs ->
Orexin receptor type 2 (4S0V)

























Residue type:  SER TYR



















3x32 2x50 3x39 7x45 7x46 Group
drd3_human D D S N S I
oprx_human D D S N S I
5ht1b_human D D S N S I
5ht2b_human D D S S S I
adrb2_human D D S N S II
acm1_human D D S N S II
acm2_human D D S N S II
acm3_rat D D S N S II
acm4_human D D S N S II
oprd_human D D S N S III
oprm_mouse D D S N S III
hrh1_human D D S N S III
aa1r_human V D S N S III
aa2ar_human V D S N S III
ox2r_human Q D S N S III
ox1r_human Q D A N S III
us28_hcmva F D S H C III
cxcr4_human Y D S H C III
par1_human F D S S C III
lpar1_human I D S N S IV
cnr1_human V D S N S IV
s1pr1_human M D S N S IV
ednrb_human Q D T N S IV
agtr1_human V D S N N IV
ntr1_rat R D T S S IV















5ht2b_human 4IB4 4 9 -5 yes I
oprx_human 5DHH 3 8 -5 yes I
5ht1b_human 4IAR 5 9 -4 yes I
drd3_human 3PBL 2 5 -3 yes I
acm1_human 5CXV 4 5 -1 no II
aa2ar_human 2YDO 3 6 -3 no III
aa1r_human 5UEN 4 6 -2 no III
oprm_mouse 5C1M 5 3 +2 no III
oprd_human 4RWD 7 7 0 no III
*ion entrance computed over an accumulated time of 1.5 µs (3 x 0.5 µs)
b
d
DSNS motif conservation
100% 45%
c
a
5ht1b_human
5ht2b_human
drd3_human
oprx_human
oprm_mouse
oprd_human
hrh1_human
aa1r_humanaa2r_human
cxcr4_human
par1_human
us28_hcmva
acm1 _human
acm2 _human
acm3_rat
acm4 _human
adrb2 _human
agtr1_human
ednrb _human
ffar1 _human
lpar1 _human
ntr1_rat
ox1r _human
s1pr1 _human
ox2r _human
D2x50 binding 
D3x32 binding 
Group III
cnr1 _human
Group I
